Alpha Cognition, Inc.

Alpha Cognition, Inc.

Alpha Cognition, Inc.

Overview
Date Founded

2000

Headquarters

439 Helmcken Street,Vancouver, BC V6B 2E6

Type of Company

Public

Employees (Worldwide)

19

Industries

Pharmaceuticals
Hospitals & Patient Services

Company Description

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis (ALS). The company was founded in 2000 and is headquartered in Vancouver, Canada.

Executives & Employees

Chief Executive Officer

President & Director

Chief Financial Officer

Chief Scientific Officer

Paths to Alpha Cognition, Inc.
Potential Connections via
Relationship Science
You
Alpha Cognition, Inc.
Recent Transactions
Details Hidden

Alpha Cognition, Inc. raised money in a private placement transaction

Details Hidden

Alpha Cognition, Inc. raised money in a private placement transaction

Details Hidden

Alpha Cognition, Inc. raised money in a private placement transaction

Key Stats and Financials As of 2020
Market Capitalization
$19M
Total Enterprise Value
$648K
Earnings Per Share
$-0.99
TEVNet Income
-0.11x
Debt TEV
4.87x
Revenue
$0
Net Profit
$-5.98M
EBITDA
$-5.82M
Total Debt
$3.16M
Total Equity
$15.7K
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alpha Cognition, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alpha Cognition, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Alpha Cognition, Inc..